60 related articles for article (PubMed ID: 25034461)
1. Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case-control study 1988-2009.
Wagner P; Alvegård T; Ranstam J; Rydholm A; Vult von Steyern F; Olsson H
Cancer Causes Control; 2014 Sep; 25(9):1167-77. PubMed ID: 25034461
[TBL] [Abstract][Full Text] [Related]
2. A fifty-year review of soft tissue sarcomas in Jamaica: 1958-2007.
Gibson TN; Hanchard B; Waugh N; McNaughton D
West Indian Med J; 2012 Oct; 61(7):692-7. PubMed ID: 23620966
[TBL] [Abstract][Full Text] [Related]
3. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
4. Menstrual and reproductive factors and risk of soft tissue sarcomas.
Fioretti F; Tavani A; Gallus S; Negri E; Franceschi S; La Vecchia C
Cancer; 2000 Feb; 88(4):786-9. PubMed ID: 10679647
[TBL] [Abstract][Full Text] [Related]
5. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and reproductive factors and the risk of ovarian cancer.
Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J
Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526
[TBL] [Abstract][Full Text] [Related]
7. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma.
Xie H; Wu X; Wang S; Chang D; Pollock RE; Lev D; Gu J
Cancer; 2013 May; 119(10):1885-91. PubMed ID: 23408253
[TBL] [Abstract][Full Text] [Related]
8. Primary spermatic cord tumors: disease characteristics, prognostic factors, and treatment outcomes.
Rodríguez D; Barrisford GW; Sanchez A; Preston MA; Kreydin EI; Olumi AF
Urol Oncol; 2014 Jan; 32(1):52.e19-25. PubMed ID: 24239475
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
10. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
[TBL] [Abstract][Full Text] [Related]
11. Incidence of soft tissue sarcoma focusing on gastrointestinal stromal sarcoma in Osaka, Japan, during 1978-2007.
Nomura E; Ioka A; Tsukuma H
Jpn J Clin Oncol; 2013 Aug; 43(8):841-5. PubMed ID: 23780991
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
Kang S; Han I; Lee S; Kim W; Kim H
Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
[TBL] [Abstract][Full Text] [Related]
13. The importance of treating by histological subtype in advanced soft tissue sarcoma.
Martín Broto J; Le Cesne A; Reichardt P
Future Oncol; 2017 Jan; 13(1s):23-31. PubMed ID: 27918201
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
15. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
16. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
18. Risk of brain tumors associated with exposure to exogenous female sex hormones.
Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
[TBL] [Abstract][Full Text] [Related]
19. Necrosis observed on CT enhancement is of prognostic value in soft tissue sarcoma.
Gustafson P; Herrlin K; Biling L; Willén H; Rydholm A
Acta Radiol; 1992 Sep; 33(5):474-6. PubMed ID: 1327028
[TBL] [Abstract][Full Text] [Related]
20. Incidence of soft tissue sarcoma in Taiwan: A nationwide population-based study (2007-2013).
Hung GY; Horng JL; Chen PC; Lin LY; Chen JY; Chuang PH; Chao TC; Yen CC
Cancer Epidemiol; 2019 Jun; 60():185-192. PubMed ID: 31055220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
